Last update:

Weight management news

GLP-1 weight-loss boom linked to surge in poison control calls

As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study.

Alcohol absorption nearly doubles after bariatric surgery, raising long-term misuse risk

Your body absorbs alcohol much more rapidly after bariatric surgery. Patients need to know this when they choose the kind of surgery they will have. "Bariatric surgery can come with a price. Patients have a significantly ...

Will GLP-1s lead to fewer prescriptions for older adults?

As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...

'Food noise' discussion on social media helps define the term

With the rise of weight-loss drugs such as GLP-1 medications in recent years, the phrase "food noise" has taken off, particularly in conversations about health and wellness on social media. While thinking about food during ...

Can't stick to a diet? Try intermittent fasting for weight loss

Yo-yo dieters who struggle to lose weight and keep it off may achieve better results by following an intermittent fasting diet, rather than traditional calorie counting. An Adelaide University study focusing on the psychological ...

Why weight‑loss drugs don't work for some people

Weight-loss jabs are the latest craze for shedding a few pounds. Their effect has been dramatic, with drugs such as Ozempic and Wegovy (semaglutide) causing users to lose up to 15% of their body fat on average.

Beyond GLP-1s: The next chapter of obesity care

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.

An economic case for teen weight-loss surgery

Metabolic and bariatric surgery for teens with severe obesity was found to be cost-effective over 10 years, according to a new analysis from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Network Open. ...